176 related articles for article (PubMed ID: 17445796)
21. Role of L-type calcium channels in pacing-induced short-term and long-term cardiac memory in canine heart.
Plotnikov AN; Yu H; Geller JC; Gainullin RZ; Chandra P; Patberg KW; Friezema S; Danilo P; Cohen IS; Feinmark SJ; Rosen MR
Circulation; 2003 Jun; 107(22):2844-9. PubMed ID: 12756152
[TBL] [Abstract][Full Text] [Related]
22. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model.
Takahara A; Konda T; Enomoto A; Kondo N
Biol Pharm Bull; 2004 Sep; 27(9):1388-91. PubMed ID: 15340224
[TBL] [Abstract][Full Text] [Related]
24. Different effects of L-type and L+N-type calcium channel blockers on hamster cheek pouch venules.
Kushiro T; Watanabe N; Takahashi A; Koike M; Saito F; Otsuka Y; Kanmatsuse K
J Cardiovasc Pharmacol; 2004 Dec; 44(6):672-5. PubMed ID: 15550786
[TBL] [Abstract][Full Text] [Related]
25. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
Kishi T; Hirooka Y; Konno S; Sunagawa K
Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
[TBL] [Abstract][Full Text] [Related]
26. Effects of the L/N-type calcium channel antagonist cilnidipine on morning blood pressure control and peripheral edema formation.
Narita S; Yoshioka Y; Ide A; Kadokami T; Momii H; Yoshida M; Ando S
J Am Soc Hypertens; 2011; 5(5):410-6. PubMed ID: 21640687
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the direct negative dromotropic effect of a new calcium channel blocker, cilnidipine, with that of nicardipine.
Sugiyama A; Satoh Y; Takahara A; Ando K; Nakamura Y; Hashimoto K
Heart Vessels; 2005 May; 20(3):112-5. PubMed ID: 15912307
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog.
Ishizaka T; Takahara A; Iwasaki H; Mitsumori Y; Kise H; Nakamura Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):135-43. PubMed ID: 19906049
[TBL] [Abstract][Full Text] [Related]
29. Effects of cilnidipine on sympathetic outflow and sympathetic arterial pressure and heart rate regulations in rats.
Yamamoto H; Kawada T; Shimizu S; Kamiya A; Miyazaki S; Sugimachi M
Life Sci; 2013 Jul; 92(24-26):1202-7. PubMed ID: 23688866
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of L/N-type and L-type calcium channel blockers on post-infarct cardiac remodelling in spontaneously hypertensive rats.
Naseratun N; Kobara M; Watanabe Y; Toba H; Nakata T
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1545-1553. PubMed ID: 32323339
[TBL] [Abstract][Full Text] [Related]
31. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F
Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
[TBL] [Abstract][Full Text] [Related]
32. Effect of cilnidipine, a novel dihydropyridine Ca2+ channel blocker, on adrenal catecholamine secretion in anesthetized dogs.
Nagayama T; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
J Cardiovasc Pharmacol; 1998 Sep; 32(3):479-84. PubMed ID: 9733363
[TBL] [Abstract][Full Text] [Related]
33. Cilnidipine, an L/N-type calcium channel blocker prevents acquisition and expression of ethanol-induced locomotor sensitization in mice.
Bhutada P; Mundhada Y; Patil J; Rahigude A; Zambare K; Deshmukh P; Tanwar D; Jain K
Neurosci Lett; 2012 Apr; 514(1):91-5. PubMed ID: 22402189
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic responses to nifedipine in dogs anesthetized with halothane.
Tosone SR; Reves JG; Kissin I; Smith LR; Fournier SE
Anesth Analg; 1983 Oct; 62(10):903-8. PubMed ID: 6614523
[TBL] [Abstract][Full Text] [Related]
35. Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles.
Konno Y; Kimura K
Int Heart J; 2008 Nov; 49(6):723-32. PubMed ID: 19075488
[TBL] [Abstract][Full Text] [Related]
36. The L/N-type calcium channel blocker, Cilnidipine, reduces heart rate and albuminuria in patients with type 2 diabetes.
Tanaka M
J Int Med Res; 2010; 38(2):602-10. PubMed ID: 20515573
[TBL] [Abstract][Full Text] [Related]
37. Preferential inhibition of L- and N-type calcium channels in the rat hippocampal neurons by cilnidipine.
Murai Y; Uneyama H; Ishibashi H; Takahama K; Akaike N
Brain Res; 2000 Jan; 854(1-2):6-10. PubMed ID: 10784100
[TBL] [Abstract][Full Text] [Related]
38. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
39. Suppression of formalin-induced nociception by cilnidipine, a voltage-dependent calcium channel blocker.
Koganei H; Shoji M; Iwata S
Biol Pharm Bull; 2009 Oct; 32(10):1695-700. PubMed ID: 19801830
[TBL] [Abstract][Full Text] [Related]
40. Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy.
Fujisawa T; Ikegami H; Noso S; Hiromine Y; Kawabata Y; Nishino M; Asano K; Ogihara T
J Diabetes Complications; 2007; 21(4):252-7. PubMed ID: 17616356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
